3.4. SLT-VEGF Depletes Tumor Vasculature of VEGFR-2 Positive Cells, but Does Not Affect Tumor Growth, Metastatic Dissemination, Tumor Recurrence, and Overall Survival in a Mouse Host Whose Line IV Cl 1 Melanoma Tumors Have a Longer Dormancy Period. This evidence concerns the gene KDR and melanoma.